Norha, Jooa http://orcid.org/0000-0002-1166-334X
Sjöros, Tanja
Garthwaite, Taru
Laine, Saara
Saarenhovi, Maria
Kallio, Petri
Laitinen, Kirsi
Houttu, Noora
Vähä-Ypyä, Henri
Sievänen, Harri http://orcid.org/0000-0003-3172-248X
Löyttyniemi, Eliisa
Vasankari, Tommi http://orcid.org/0000-0001-7209-9351
Knuuti, Juhani
Kalliokoski, Kari K. http://orcid.org/0000-0002-8893-7126
Heinonen, Ilkka H. A.
Article History
Received: 16 June 2023
Revised: 9 January 2024
Accepted: 11 January 2024
First Online: 24 January 2024
Competing interests
: TS received a speaker fee from Pihlajalinna Plc, Tampere, Finland; and JK received consultancy fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim and Merck, outside of the submitted work. The other authors report no conflicts of interest. The results are presented clearly and honestly without fabrication, falsification or inappropriate data manipulation.
: This study was conducted according to the Declaration of Helsinki and the Ethics Committee of the Hospital District of Southwest Finland gave approval for the study (16/1801/2017).